BriaCell Therapeutics Corp. filed a registration statement with the SEC, utilizing ThinkEquity as the sole placement agent.
1 report, 1 independent
Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BriaCell Therapeutics Corp. filed a registration statement with the SEC, utilizing ThinkEquity as the sole placement agent.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
ThinkEquity
US investment banking firm
Nothing else this week.
-
Securities and Exchange Commission (Bangladesh)
government regulatory body overseeing the stock market
Coverage
Newest first; wire copies grouped- GlobeNewswireBriaCell Therapeutics Announces Pricing of $15 million Public Offering PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW